Q5U2R3
Gene name |
Frmd8 |
Protein name |
FERM domain-containing protein 8 |
Names |
|
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:309172 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5U2R3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5U2R3-F1 | Predicted | AlphaFoldDB |
No variants for Q5U2R3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q5U2R3 | |||||
No associated diseases with Q5U2R3
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| centriolar satellite | A small (70-100 nm) cytoplasmic granule that contains a number of centrosomal proteins; centriolar satellites traffic toward microtubule minus ends and are enriched near the centrosome. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of canonical Wnt signaling pathway | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| positive regulation of tumor necrosis factor production | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
| protein localization to plasma membrane | A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEGAEGNAGQ | PGPAERSHRS | SVSSVGARAA | DVLVYLADDT | VVPLAVENLS | SISAHELHRA |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VREVLQLPDM | ALEAFALWLV | SPLLEVQLKP | KHQPYKLGRQ | WPELLLRFTD | ASDDDIAMDE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| PSLQFRRNVF | FPKRRELQVH | DEEVLRLLYE | EAKGNVLTAR | YPCDLEDCEV | LGGLVCRVQL |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GPYQPGQPAA | CTVREKLDSF | LPAHLCKRGH | GLFAAFRGRG | AKTGPCEQGL | LNAYRQVKEM |
| 250 | 260 | 270 | 280 | 290 | 300 |
| AGGDSERETT | LGSHYRAYLL | KCHELPFYGC | AFFHGEVDKP | TQGFLHRGGR | KPVTVAISLE |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GVHVIDNREK | HVLLGLRFQE | LSWDHTSPEE | EEPVLWLEFD | GDSEGTPVNK | LLRIYSKQAE |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LMSVLIEYCI | ELSQAAEPAL | PQESASGPQE | APSPSSAPTQ | RPKLRRQGSV | VCSRIQHLST |
| 430 | 440 | 450 | 460 | ||
| IDYVEDGSGI | KRVKPKRTTS | FFSRQLSSSH | GSYTVVQPND | NSPEQG |